In the rapidly expanding field of peptide therapeutics, the short in vivo half-life of peptides represents a considerable limitation for drug action. D-peptides, consisting entirely of the dextrorotatory enantiomers of naturally occurring levorotatory amino acids (AAs), do not suffer from these shortcomings as they are intrinsically resistant to proteolytic degradation, resulting in a favourable pharmacokinetic profile. To experimentally identify D-peptide binders to interesting therapeutic targets, so-called mirror-image phage display is typically performed, whereby the target is synthesized in D-form and L-peptide binders are screened as in conventional phage display. This technique is extremely powerful, but it requires the synthesis of the target in D-form, which is challenging for large proteins. Here we present finDr, a novel web server for the computational identification and optimization of D-peptide ligands to any protein structure ( https://findr.biologie.uni-freiburg.de/ ). finDr performs molecular docking to virtually screen a library of helical 12-mer peptides extracted from the RCSB Protein Data Bank (PDB) for their ability to bind to the target. In a separate, heuristic approach to search the chemical space of 12-mer peptides, finDr executes a customizable evolutionary algorithm (EA) for the de novo identification or optimization of D-peptide ligands. As a proof of principle, we demonstrate the validity of our approach to predict optimal binders to the pharmacologically relevant target phenol soluble modulin alpha 3 (PSMα3), a toxin of methicillin-resistant Staphylococcus aureus (MRSA). We validate the predictions using in vitro binding assays, supporting the success of this approach. Compared to conventional methods, finDr provides a low cost and easy-to-use alternative for the identification of D-peptide ligands against protein targets of choice without size limitation. We believe finDr will facilitate D-peptide discovery with implications in biotechnology and biomedicine.
Dependently-typed programming languages are gaining importance, because they can guarantee a wide range of properties at compile time. Their use in practice is often hampered because programmers have to provide very precise types. Gradual typing is a means to vary the level of typing precision between program fragments and to transition smoothly towards more precisely typed programs. The combination of gradual typing and dependent types seems promising to promote the widespread use of dependent types. We investigate a gradual version of a minimalist value-dependent lambda calculus. Compile-time calculations and thus dependencies are restricted to labels, drawn from a generic enumeration type. The calculus supports the usual Pi and Sigma types as well as singleton types and subtyping. It is sufficiently powerful to provide flexible encodings of variant and record types with first-class labels. We provide type checking algorithms for the underlying label-dependent lambda calculus and its gradual extension. The gradual type checker drives the translation into a cast calculus, which extends the original language. The cast calculus comes with several innovations: refined typing for casts in the presence of singletons, type reduction in casts, and fully dependent Sigma types. Besides standard metatheoretical results, we establish the gradual guarantee for the gradual language.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.